Measurement of patient reported gastrointestinal (GI) and health-related quality of life (HRQL) outcomes in liver transplant recipients (MyLiver).
Phase of Trial: Phase III
Latest Information Update: 05 Feb 2014
At a glance
- Drugs Mycophenolate sodium (Primary)
- Indications Liver transplant rejection
- Focus Therapeutic Use
- Acronyms MyLiver
- Sponsors Novartis
- 16 Jun 2009 Actual end date (Sep 2008) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Planned number of patients changed from 194 to 34 as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.